TrialJournal of clinical immunology2016

Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency.

Mikhail A Rojavin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.